These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 14734482

  • 21. Autoimmune pancreatitis in MRL/Mp mice is a T cell-mediated disease responsive to cyclosporine A and rapamycin treatment.
    Schwaiger T, van den Brandt C, Fitzner B, Zaatreh S, Kraatz F, Dummer A, Nizze H, Evert M, Bröker BM, Brunner-Weinzierl MC, Wartmann T, Salem T, Lerch MM, Jaster R, Mayerle J.
    Gut; 2014 Mar; 63(3):494-505. PubMed ID: 23564336
    [Abstract] [Full Text] [Related]

  • 22. Everolimus (RAD) inhibits in vivo growth of murine squamous cell carcinoma (SCC VII).
    Khariwala SS, Kjaergaard J, Lorenz R, Van Lente F, Shu S, Strome M.
    Laryngoscope; 2006 May; 116(5):814-20. PubMed ID: 16652094
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-Met inhibition.
    Nakachi I, Naoki K, Soejima K, Kawada I, Watanabe H, Yasuda H, Nakayama S, Yoda S, Satomi R, Ikemura S, Terai H, Sato T, Ishizaka A.
    Mol Cancer Res; 2010 Aug; 8(8):1142-51. PubMed ID: 20647329
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.
    Kenessey I, Kói K, Horváth O, Cserepes M, Molnár D, Izsák V, Dobos J, Hegedűs B, Tóvári J, Tímár J.
    Oncotarget; 2016 Nov 29; 7(48):79503-79514. PubMed ID: 27780929
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
    Wang YY, Lv YF, Lu L, Cai L.
    Anticancer Drugs; 2014 Nov 29; 25(10):1192-200. PubMed ID: 25075795
    [Abstract] [Full Text] [Related]

  • 34. Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.
    Wai LE, Fujiki M, Takeda S, Martinez OM, Krams SM.
    Transplantation; 2008 Jan 15; 85(1):145-9. PubMed ID: 18192925
    [Abstract] [Full Text] [Related]

  • 35. Human endostatin inhibits growth of human non-small-cell lung cancer in a murine xenotransplant model.
    Boehle AS, Kurdow R, Schulze M, Kliche U, Sipos B, Soondrum K, Ebrahimnejad A, Dohrmann P, Kalthoff H, Henne-Bruns D, Neumaier M.
    Int J Cancer; 2001 Nov 01; 94(3):420-8. PubMed ID: 11745424
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.